Cargando…
COVID-19 vaccination and HIV-1 acquisition
Autores principales: | Logunov, Denis Y, Livermore, David M, Ornelles, David A, Bayer, Wibke, Marques, Ernesto, Czerkinsky, Cecil, Dolzhikova, Inna V, Ertl, Hildegund CJ |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989395/ https://www.ncbi.nlm.nih.gov/pubmed/35397866 http://dx.doi.org/10.1016/S0140-6736(22)00332-4 |
Ejemplares similares
-
Safety and efficacy of the Russian COVID-19 vaccine: more information needed – Authors’ reply
por: Logunov, Denis Y, et al.
Publicado: (2020) -
Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial – Authors' reply
por: Logunov, Denis Y, et al.
Publicado: (2021) -
Adenoviral Vector Vaccines Antigen Transgene
por: Ertl, Hildegund C.J.
Publicado: (2016) -
Adenoviruses as vaccine vectors
por: Tatsis, Nia, et al.
Publicado: (2004) -
Back to the Future: Can Vaccines Win the Long-Term Fight Against COVID-19?
por: Ertl, Hildegund C. J., et al.
Publicado: (2022)